Harald Tammen
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Quantitative mass spectrometric analysis of C-terminal 36 amino acid peptides of alpha-1 antitrypsin in plasma using survey spectra.
Journal: Methods (San Diego, Calif.)
Published: January 14, 2025
Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans.
Journal: Scientific reports
Published: May 27, 2022
Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice.
Journal: Scientific reports
Published: February 22, 2021
Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: December 10, 2020
Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy.
Journal: Kidney international
Published: April 26, 2018
The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.
Journal: Cardiovascular diabetology
Published: February 26, 2018
Data Preprocessing, Visualization, and Statistical Analyses of Nontargeted Peptidomics Data from MALDI-MS.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 25, 2018
The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
Journal: Kidney international
Published: March 17, 2015
Collection and handling of blood specimens for peptidomics.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 15, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026